SLC7A2 intronic transcript 1 (SLC7A2-IT1)

SLC7A2 intronic transcript 1 (SLC7A2-IT1) likely refers to a long non-coding RNA (lncRNA) or uncharacterized transcript originating within the intronic region of the SLC7A2 gene. There is no evidence in major genomic, proteomic, or drug-target databases that SLC7A2-IT1 is a protein, enzyme, receptor, transporter, or otherwise druggable molecule. All well-established therapeutic interest surrounds the SLC7A2 gene product: a cationic amino acid transporter (CAT-2), associated with arginine, lysine, and ornithine uptake and implicated in immune regulation, cancer, inflammation, and neurodegeneration[1][2][3]. SLC7A2-IT1 itself is not described as a target in the literature, and there is no current evidence that it is a therapeutic target or that it possesses druggability or biomarker status.

Not applicable for SLC7A2-IT1.